Paramount BioCapital Asset Management
North America, New York, United States, New York
Description
Paramount BioSciences is a global pharmaceutical development and healthcare investment firm that conceives, nurtures, and supports new
Investor Profile
Paramount BioCapital Asset Management has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Post Ipo Equity (60%)
- Series Unknown (40%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Medical
- Biopharma
- Genetics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
